Collateral sensitivity of antibiotic-resistant microbes

被引:178
作者
Pal, Csaba [1 ]
Papp, Balazs [1 ]
Lazar, Viktoria [1 ]
机构
[1] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, Synthet & Syst Biol Unit, H-6701 Szeged, Hungary
基金
欧洲研究理事会; 英国惠康基金;
关键词
collateral sensitivity; antibiotic resistance; experimental evolution; cross-resistance; multidrug resistance; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; MULTIDRUG-RESISTANCE; EVOLUTIONARY PATHS; GENE-EXPRESSION; DETERMINANTS; SELECTION; SUSCEPTIBILITY; MUTANTS; COST;
D O I
10.1016/j.tim.2015.02.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Understanding how evolution of microbial resistance towards a given antibiotic influences susceptibility to other drugs is a challenge of profound importance. By combining laboratory evolution, genome sequencing, and functional analyses, recent works have charted the map of evolutionary trade-offs between antibiotics and have explored the underlying molecular mechanisms. Strikingly, mutations that caused multidrug resistance in bacteria simultaneously enhanced sensitivity to many other unrelated drugs (collateral sensitivity). Here, we explore how this emerging research sheds new light on resistance mechanisms and the way it could be exploited for the development of alternative antimicrobial strategies.
引用
收藏
页码:401 / 407
页数:7
相关论文
共 38 条
  • [1] [Anonymous], 2013, COCHRANE DATABASE SY
  • [2] Physiology and antibiotic susceptibility of Staphylocoecus aureus small colony variants
    Baumert, N
    Von Eiff, C
    Schaaff, F
    Peters, G
    Proctor, RA
    Sahl, HG
    [J]. MICROBIAL DRUG RESISTANCE, 2002, 8 (04) : 253 - 260
  • [3] An experimental test of evolutionary trade-offs during temperature adaptation
    Bennett, Albert F.
    Lenski, Richard E.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 : 8649 - 8654
  • [4] Molecular analysis of fusidic acid resistance in Staphylococcus aureus
    Besier, S
    Ludwig, A
    Brade, V
    Wichelhaus, TA
    [J]. MOLECULAR MICROBIOLOGY, 2003, 47 (02) : 463 - 469
  • [5] gyrA mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli
    Conrad, S
    Oethinger, M
    Kaifel, K
    Klotz, G
    Marre, R
    Kern, WV
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (03) : 443 - 455
  • [6] An RpoB Mutation Confers Dual Heteroresistance to Daptomycin and Vancomycin in Staphylococcus aureus
    Cui, Longzhu
    Isii, Taisuke
    Fukuda, Minoru
    Ochiai, Tomonori
    Neoh, Hui-min
    Camargo, Ilana Lopes Baratella da Cunha
    Watanabe, Yukiko
    Shoji, Mitsutaka
    Hishinuma, Tomomi
    Hiramatsu, Keiichi
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (12) : 5222 - 5233
  • [7] ROLE OF THE MEMBRANE-POTENTIAL IN BACTERIAL-RESISTANCE TO AMINOGLYCOSIDE ANTIBIOTICS
    DAMPER, PD
    EPSTEIN, W
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 20 (06) : 803 - 808
  • [8] Evolutionary potential, cross-stress behavior and the genetic basis of acquired stress resistance in Escherichia coli
    Dragosits, Martin
    Mozhayskiy, Vadim
    Quinones-Soto, Semarhy
    Park, Jiyeon
    Tagkopoulos, Ilias
    [J]. MOLECULAR SYSTEMS BIOLOGY, 2013, 9
  • [9] The competitive cost of antibiotic resistance in Mycobacterium tuberculosis
    Gagneux, Sebastien
    Long, Clara Davis
    Small, Peter M.
    Van, Tran
    Schoolnik, Gary K.
    Bohannan, Brendan J. M.
    [J]. SCIENCE, 2006, 312 (5782) : 1944 - 1946
  • [10] Collateral damage
    Hancock, Robert E. W.
    [J]. NATURE BIOTECHNOLOGY, 2014, 32 (01) : 66 - 68